FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Around the world, wealthy countries are struggling to afford long-term care for rapidly aging populations. Most spend more than the
Read MoreWhy don’t more people take the weight-loss medications currently on the market? Despite the myriad menus of FDA-approved medications for
Read MoreReed Abelson, The New York Times and Jordan Rau, KFF Health News Margaret Newcomb, 69, a retired French teacher, is
Read More“It is emotionally and physically draining.” Natasha Lazartes with her mother, Carmen Torres, and husband, Jonathan Youngman, at her home
Read MoreNovember 13, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreCFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight
Read MoreNovember 13, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreToday we bring you the story of a patient seeking the RSV vaccine — and how her frustrating journey illustrates
Read MoreNovember 13, 2023 3 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreKatherine Wells wants to urge her Lubbock, Texas, community to get vaccinated against covid-19. “That could really save people from
Read More